Genetic Testing for Predisposition to Inherited Hypertrophic Cardiomyopathy
Summary
Under this BCBS policy, genetic testing for predisposition to hypertrophic cardiomyopathy may be considered medically necessary for individuals who have a first-degree relative with established hypertrophic cardiomyopathy, when a known pathogenic gene variant is present in that affected relative. Testing is considered investigational for individuals whose first-degree relative with established hypertrophic cardiomyopathy tested negative for pathogenic variants, and for all other populations. The policy history records an 08/18/2026 review with the policy statements unchanged and the code reference updated to remove ICD-9 diagnosis codes.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.